- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03200366
Comparing Interventions to Increase Colorectal Cancer Screening
Comparing Interventions to Increase Colorectal Cancer Screening in Low-Income and Minority Patients
The purpose of this study is to test different approaches to help people understand the purpose of colorectal cancer (CRC) screening, two screening test options available, and the barriers to screening so they can make informed decisions about CRC screening. Participants will be randomly assigned to one of three groups: (1) one group will receive a tailored digital video disc (DVD) in the mail; (2) another group will receive the mailed DVD plus telephone calls from a patient navigator; and (3) the third group will receive the care normally provided by the healthcare system's endoscopy department.
The investigators hypothesize the following: (1) participants who receive the tailored DVD plus the patient navigation intervention will have higher rates of CRC screening with the fecal immunochemical test (FIT), colonoscopy, or either screening test compared to those who receive the tailored DVD alone; (2) participants who receive either intervention (DVD only or DVD plus patient navigation) will have higher rates of CRC screening with FIT, colonoscopy, or either screening test than those who receive usual care; and (3) participants who receive either intervention who complete colonoscopy will have better quality of bowel preparation, less anxiety about the procedure, and greater satisfaction with the colonoscopy experience than those who receive usual care.
연구 개요
상세 설명
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Indiana
-
Indianapolis, Indiana, 미국, 46202
- Eskenazi Health
-
Indianapolis, Indiana, 미국, 46202
- Indiana University School of Nursing
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Referred for a screening colonoscopy that was not done (i.e, canceled or no show)
Exclusion Criteria:
- Unable to speak, read, and write English
- Personal history of CRC or polyps
- Personal history of conditions that place participants at high risk for CRC such as ulcerative colitis, Crohn's disease, or known hereditary syndromes such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer
- Family history of CRC which increases the participant's risk for CRC
- Advised by a health care provider to not have a colonoscopy due to the participant's health
- Speech impairment
- Hearing impairment
- Cognitive impairment
- Vision impairment
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 상영
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: Tailored DVD
Tailored digital video disc (DVD)
|
A 20 minute tailored DVD titled "Approaches to Colon Testing" is viewed by participants.
It is designed to encourage CRC screening uptake by colonoscopy or FIT by increasing the participant's CRC knowledge and beliefs about the benefits of screening, reducing barriers to screening, and increasing self-efficacy for screening by demonstrating how these tests are performed.
|
활성 비교기: Tailored DVD + Patient Navigation
Tailored digital video disc (DVD) plus Patient Navigation by a population health nurse in the healthcare system
|
A 20 minute tailored DVD titled "Approaches to Colon Testing" is viewed by participants.
It is designed to encourage CRC screening uptake by colonoscopy or FIT by increasing the participant's CRC knowledge and beliefs about the benefits of screening, reducing barriers to screening, and increasing self-efficacy for screening by demonstrating how these tests are performed.
Participants talk by telephone with a Patient Navigator who is a trained nurse.
The Patient Navigator determines if participants viewed the tailored DVD and answers any questions about the content.
The Patient Navigator then provides telephone counseling on CRC and screening tests to: (1) increase knowledge, perceived benefits, and self-efficacy; (2) reduce barriers; (3) enhance access; and (4) provide social support.
|
간섭 없음: Usual Care
Care normally provided by a nurse in the endoscopy department of the healthcare system
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Participants Completing CRC Screening Per Electronic Medical Record Documentation
기간: 12 months post-baseline interview
|
Number of participants completing CRC screening by any test (defined as colonoscopy or FIT) is measured by electronic medical record review.
Dates that participants had a colonoscopy and dates of FIT analysis are extracted from the electronic medical record.
|
12 months post-baseline interview
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Participants Completing Colonoscopy Per Electronic Medical Record Documentation
기간: 12 months post-baseline interview
|
Number of participants completing a colonoscopy is measured by electronic medical record review (EMR).
Dates that participants completed a colonoscopy are extracted from the EMR.
|
12 months post-baseline interview
|
Bowel Preparation Quality Rating Using Boston Bowel Preparation Scale
기간: 12 months post-baseline interview
|
Participants quality of bowel preparation is measured by the endoscopist during their colonoscopy procedure using the Boston Bowel Preparation Scale (BBPS).
BBPS scores the total quality on a 10 point scale from 0-9.
Higher scores indicate better quality of bowel preparation.
|
12 months post-baseline interview
|
Participants With Adequate Quality of Bowel Preparation Per Modified Aronchick Rating Scale
기간: 12 months post-baseline interview
|
Participants quality of bowel preparation is measured by the endoscopist during their colonoscopy using a modification of the Aronchick rating scale.
The Aronchick scale rates quality as 1=excellent, 2=good, 3=fair, or 4=poor.
Some endoscopists choose to grade quality more generally as adequate vs. inadequate.
To accommodate this variation, bowel preparation ratings have been dichotomized into adequate (excellent, good, fair, or adequate ratings) vs. inadequate (poor or inadequate ratings).
Adequate is scored as 1 and indicates better quality of bowel preparation than inadequate which is scored as 0.
|
12 months post-baseline interview
|
Colonoscopy-Related Procedural Anxiety for Participants Completing a Colonoscopy
기간: 12 months post-baseline interview
|
Colonoscopy-related procedural anxiety is measured by self-report using the 6-item short form of the State Anxiety Scale of the State-Trait Anxiety Inventory.
Each item is scored from 1 to 4 (1=not at all; 4=very much so) with higher scores indicating greater anxiety.
|
12 months post-baseline interview
|
Satisfaction With Colonoscopy Experience
기간: 12 months post-baseline interview
|
Satisfaction with the colonoscopy experience is measured by self-report using a single item developed by the research team.
Satisfaction is rated from 1 to 4 where 1=not at all satisfied, 2=a little satisfied, 3=mostly satisfied, and 4=completely satisfied.
Scores range from 1 to 4 with higher scores indicating greater satisfaction.
|
12 months post-baseline interview
|
Participants Completing a Fecal Immunochemical Test (FIT) Per Electronic Medical Record Documentation
기간: 12 months post-baseline interview
|
Number of participants completing a FIT is measured by electronic medical record review (EMR).
Dates of FIT analysis are extracted from the EMR.
|
12 months post-baseline interview
|
Participants Who Self-Reported Completing CRC Screening
기간: 6-9 months post-baseline interview
|
Number of participants who reported completing CRC screening by any test (defined as colonoscopy or FIT) during the 6 or 9 month post-baseline telephone interview.
|
6-9 months post-baseline interview
|
Participants Who Self-Reported Completing a Colonoscopy
기간: 6-9 months post-baseline interview
|
Number of participants who reported completing a colonoscopy during the 6 or 9 month post-baseline telephone interview.
|
6-9 months post-baseline interview
|
Participants Who Self-Reported Completing a Fecal Immunochemical Test (FIT)
기간: 6-9 months post-baseline interview
|
Number of participants who reported completing a FIT during the 6 or 9 month post-baseline telephone interview.
|
6-9 months post-baseline interview
|
Change in Knowledge of CRC and Screening
기간: 6 months post-baseline interview
|
Change from baseline in knowledge of CRC and screening is measured at 6 months by self-report using a 9-item multidimensional scale.
Each item is scored as 1=correct or 0=incorrect and summed to yield a scale score.
Scores range from 0 to 9 with higher summated scores indicating greater knowledge of CRC and screening tests.
The mean of the 9 items is calculated at baseline and 6 months post-baseline.
Change from baseline equals the mean at 6 months minus the mean at baseline.
Change can range from -9 to 9 with positive values indicating an increase in knowledge.
|
6 months post-baseline interview
|
Change in Perceived Risk for CRC
기간: 6 months post-baseline interview
|
Change from baseline in perceived risk for CRC is measured by self-report at 6 months using a 3-item scale.
We ask participants how likely it is that they will get colon cancer sometime during their lifetime, within the next 10 years, and within the next 5 years.
Each item is scored from 1 to 4 (1=very unlikely; 4=very likely).
Higher scores indicate a higher perceived risk for getting CRC.
The mean of the 3 items is calculated at baseline and 6 months.
Change in perceived risk equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived risk for getting CRC.
|
6 months post-baseline interview
|
Change in Colonoscopy-Related Procedural Anxiety Regardless of Whether or Not Participants Had a Colonoscopy
기간: 6 months post-baseline interview
|
Change from baseline in colonoscopy-related procedural anxiety is measured at 6 months by self-report using the 6-item short form of the State Anxiety Scale of the State-Trait Anxiety Inventory.
Each item is scored from 1 to 4 (1=not at all; 4=very much so) with higher scores indicating greater anxiety.
The mean of the 6 items is calculated at baseline and 6 months post-baseline.
Change from baseline is the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in anxiety.
|
6 months post-baseline interview
|
Change in Perceived Benefits of CRC Screening by Colonoscopy
기간: 6 months post-baseline interview
|
Change from baseline in perceived benefits of CRC screening by colonoscopy is measured at 6 months by self-report using a 4-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 4 items calculated.
Higher mean scores indicate greater perceived benefits of screening by colonoscopy.
Change in perceived benefits equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived benefits of screening by colonoscopy.
|
6 months post-baseline interview
|
Change in Perceived Barriers to CRC Screening by Colonoscopy
기간: 6 months post-baseline interview
|
Change from baseline in perceived barriers to CRC screening by colonoscopy is measured at 6 months by self-report using a 16-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 16 items calculated.
Higher mean scores indicate greater perceived barriers to screening by colonoscopy.
Change in perceived barriers equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with negative values indicating a decrease in perceived barriers to screening by colonoscopy.
|
6 months post-baseline interview
|
Change in Perceived Self-Efficacy for CRC Screening by Colonoscopy
기간: 6 months post-baseline interview
|
Change from baseline in perceived self-efficacy for colonoscopy is measured at 6 months by self-report using an 11-item scale.
Each item is scored from 1 to 4 (1=not at all sure; 4=very sure) and the mean of the 11 items calculated.
Higher mean scores indicate greater perceived self-efficacy for screening by colonoscopy.
Change in perceived self-efficacy equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived self-efficacy for screening by colonoscopy.
|
6 months post-baseline interview
|
Change in Perceived Benefits of CRC Screening by FIT
기간: 6 months post-baseline interview
|
Change from baseline in perceived benefits of CRC screening by FIT is measured at 6 months by self-report using a 3-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 3 items calculated.
Higher mean scores indicate greater perceived benefits of screening by FIT.
Change in perceived benefits equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived benefits for screening by FIT.
|
6 months post-baseline interview
|
Change in Perceived Barriers to CRC Screening by FIT
기간: 6 months post-baseline interview
|
Change from baseline in perceived barriers to CRC screening by FIT is measured at 6 months by self-report using a 10-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 10 items calculated.
Higher mean scores indicate greater perceived barriers to screening by FIT.
Change in perceived barriers equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with negative values indicating a decrease in perceived barriers to screening by FIT.
|
6 months post-baseline interview
|
Change in Perceived Self-Efficacy for CRC Screening by FIT
기간: 6 months post-baseline interview
|
Change from baseline in perceived self-efficacy for CRC screening by FIT is measured at 6 months by self-report using a 7-item scale.
Each item is scored from 1 to 4 (1=not at all sure; 4=very sure) and the mean of the 7 items calculated.
Higher mean scores indicate greater perceived self-efficacy for screening by FIT.
Change in perceived self-efficacy equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived self-efficacy for screening by FIT.
|
6 months post-baseline interview
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Susan M Rawl, PhD,RN, Indiana University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 1605880142
- IHS-1507-31333 (기타 보조금/기금 번호: Patient-Centered Outcomes Research Institute (PCORI))
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
대장암에 대한 임상 시험
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen Breast Cancer...완전한
-
University of UtahNational Cancer Institute (NCI)모병피로 | 좌식 생활 | 전이성 전립선암 | IV기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVA기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVB기 전립선암 AJCC(American Joint Committee on Cancer) v8미국
-
Jonsson Comprehensive Cancer Center아직 모집하지 않음전립선암 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Rashmi Verma, MDNational Cancer Institute (NCI)모병거세저항성 전립선암 | 전이성 전립선 선암종 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center빼는전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterMiraDX모집하지 않고 적극적으로전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center종료됨거세저항성 전립선암 | 전이성 전립선암 | IVA기 전립선암 AJCC v8 | IVB기 전립선암 AJCC v8 | IV기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.종료됨2기 전립선암 AJCC v8 | IIIA기 전립선암 AJCC v8 | IIIB기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | 3기 전립선암 AJCC v8 | IIIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Assiut University아직 모집하지 않음South Egypt Cancer Institute(SECI)에서 소아 악성종양 환자에 대한 KDIGO 기준을 사용하여 AKI의 누적 발병률을 확인하기 위해
-
Jonsson Comprehensive Cancer Center종료됨생화학적으로 재발하는 전립선암 | 전이성 전립선암 | 뼈의 전이성 악성 신생물 | IVA기 전립선암 AJCC v8 | IVB기 전립선암 AJCC v8 | IV기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
Tailored DVD에 대한 임상 시험
-
The Miriam HospitalNational Institute of Mental Health (NIMH); Brown University; University of Rochester; Syracuse...완전한
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong Kong완전한
-
University of Texas Southwestern Medical CenterAgency for Healthcare Research and Quality (AHRQ)완전한
-
University of RochesterThe Commonwealth Fund; Academic Pediatric Association완전한
-
University of DelawareNational Institute on Drug Abuse (NIDA)완전한
-
IRCSS Istituto Dermopatico dell'Immacolata, Fondazione...Ministry of Health, Italy; Centro di Eccellenza per la Cultura e la Ricerca Infermieristica...완전한